本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kymera Therapeutics, Inc.

25.97
+0.95003.80%
盘后:25.970.00000.00%16:35 EDT
成交量:46.88万
成交额:1,199.72万
市值:16.87亿
市盈率:-8.71
高:26.03
开:25.00
低:24.72
收:25.02
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
更多
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
数据加载中...
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

如果下载按钮点击无跳转,请点击右上角菜单选择 “在浏览器打开”